Why the study?
Prior health economic analyses of the Global Polio Eradication Initiative assumed eradication by 2012, requiring an update given delays in eradication and increased costs.
Population
Global population
Comparison
Global Polio Eradication Initiative trajectory vs no eradication baseline
Design
Integrated global economic modeling study
Follow-up
Time horizon of 1988-2029
Key result
The Global Polio Eradication Initiative is estimated to yield incremental net benefits of 28 billion US$2019 over the 1988–2029 time horizon, assuming eradication is achieved in 2023.
Authors
Loading...
Expected net benefits support sustained eradication investments; leaves open effects of further delays on cost-effectiveness.
Effect estimate: 28 billion US$2019
Despite delays and increased costs, the Global Polio Eradication Initiative continues to yield expected incremental net benefits globally, estimated at 28 billion US$2019 if eradication is achieved by 2023.
Thompson et al. (2021) studied Poliomyelitis. Global Polio Eradication Initiative (GPEI) vs. No GPEI (routine immunization only) was evaluated on Incremental net benefits (INB) (28 billion US$2019). The Global Polio Eradication Initiative is estimated to yield incremental net benefits of 28 billion US$2019 over the 1988–2029 time horizon, assuming eradication is achieved in 2023.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: